MedTrace Logo

Acute Kidney Injury in Patients With Acute Respiratory Distress Syndrome

NCT04154007 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2019-11-06

No results posted yet for this study

Summary

Several studies suggested that ARDS may have important adverse effects on renal function, but few studies have specifically addressed the risk factors of AKI and its impact on the outcome in theses patients.

Conditions

Interventions

DIAGNOSTIC_TEST

kidney function tests - urine output

AKI was classified based on the worst of either creatinine or urine output criterion as follows: Stage I 1.5-1.9 times baseline OR ≥0.3 mg/dl increase in the serum creatinine, OR urine output \<0.5 ml/kg per hour for 6 to 12 hours. Stage II 2.0-2.9 times baseline increase in the serum creatinine OR urine output \<0.5 ml/kg per hour for ≥12 hours. Stage III 3.0 times baseline increase in the serum creatinine OR increase in serum creatinine to ≥4.0 mg OR urine output of \<0.3 ml/kg per hour for ≥24 hours, OR anuria for ≥12 hours OR the initiation of renal replacement therapy.

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Principal Investigators

  • Eman Shebl, MD · Chest department, Faculty of Medicine, Zagazig University

  • Lamiaa G Zake, MD · Chest department, Faculty of Medicine, Zagazig University

  • Sherif MS Mowafy, MD · Anesthesia and Surgical Intensive Care department, Faculty of Medicine, Zagazig University

  • Ayman R Abd El-Hameed, MD · Nephrology Internal Medicine department, Faculty of Medicine, Zagazig University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2019-03-30
Completion
2019-03-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04154007 on ClinicalTrials.gov